Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman of any age who is currently pregnant or have been pregnant within the last year
- You are willing to take part and have signed and dated a consent form confirming you understand what the study involves
- You agree to allow your healthcare provider(s) to share your medical information with the registry
- You either received at least one dose of a medication called CIBINQO at some point during pregnancy or up to one day before becoming pregnant, OR you have been diagnosed with moderate-to-severe eczema (atopic dermatitis) at any point before the end of your pregnancy
Who may not be able to join:
- You do not meet any of the requirements listed above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent of live birth children with major congenital malformations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.